Latest News

  • Kalbe’s First Quarter 2013 Sales Increased by 16.2%

    Thursday, April 25, 2013

    Jakarta, April 25, 2013 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced net sales of Rp 3,490 billion for the first quarter of 2013, an increase of 16.2% compared to the first quarter of 2012 of Rp 3,005 billion.

  • Kalbe Presents Beach Adventure In A Mall

    Growing Family Love of the Beach and the Ocean

    Thursday, April 11, 2013

    Jakarta, 11 April 2013 – PT Kalbe Farma Tbk (Kalbe) through Hydro Coco brand is holding Hydro Coco Beach, a beach adventure inside a mall. That is the event where Hydro Coco is presenting the beach atmosphere and habitat inside the mall. The event is held with the purpose to introduce the Indonesian family, especially the children, to the biodiversity of ocean life and the benefit of coconut water that came from the beach and ocean habitat.  The event is held from 11 April to 14 April 2013 at Mall Kelapa Gading 3, Jakarta, and continued on 2-5 May 2013 at Mall Summarecon Serpong.

  • Kalbe Boosts Children's Interest For Science

    Launching Kalbe Junior Scientist Award (KJSA) 2013

    Tuesday, April 9, 2013

    Jakarta, 9 April 2013 – Today, PT Kalbe Farma Tbk (Kalbe) start the socialization of the series of activities of Kalbe Junior Scientist Award (KJSA) 2013, a tournament of science competition at the level of elementary school throughout Indonesia, by holding an educational discussion with the theme "Science Education in Elementary School Curiculum 2013", held at the Financial Club, Graha CIMB Jakarta. Through the discussion, it is expected that a change to the elementary school curiculum, particularly in science, can be vieved positively and would encourage children to learn and love science.

  • Net Profit for 2012 Increased by 17.0%

    Thursday, March 28, 2013

    Jakarta, March 28, 2013 – PT Kalbe Farma Tbk (“Kalbe” or “the Company”) today announced the Company’s performance for the year 2012 based on Audited Consolidated Financial Statements for the year ending December 31, 2012 of PT Kalbe Farma Tbk and Subsidiaries.

  • Kalbe Launches Vitek MS

    The Newest Technology on Clinical Microbiology to Increase Healthcare Services

    Thursday, March 28, 2013

    Jakarta, 28 March 2013 – PT Kalbe Farma Tbk (Kalbe) through its subsidiary PT Enseval Medika Prima (EMP)  is launching the Vitek Mass Spectrophotometry (Vitek MS) today, a medical device with a new technology in the microbiological test in the blood that would assist the enforcement of diagnosis and determination of the function of the use of antibiotics to be more precise and rational.